Zissiadis, Yvonne

A/Prof Yvonne Zissiadis

Radiation Oncologist; Medical Director, GenesisCare WA; Adjunct Associate Professor, Curtin University, Department of Health Sciences
Yvonne completed her general medical training in Western Australia before moving east to the Peter MacCallum Cancer Institute in Victoria to complete her training in radiation oncology. The offer of a fellowship in breast cancer at the Breast Cancer Institute, Westmead Hospital saw her move to Sydney, and this was followed by a position as a consultant radiation oncologist at the Prince of Wales Hospital in Randwick then a clinical fellowship at Massachusetts General Hospital. On returning to Perth, she began working as a consultant radiation oncologist at Royal Perth Hospital and joined GenesisCare in 2011.

Yvonne is the Medical Director for GenesisCare WA and the WA Representative to the CLF (Clinical Leaders Forum). She also Chairs the GenesisCare Breast Expert Advisory Group has been a member of the RANZCR Economics and Workforce Committee. As Adjunct Associate Professor at Curtin University (Dept of Health Sciences) and conjoint lectureships at ECU and UWA, she continues her work in exercise implementation, value-based healthcare, patient navigation and innovative RT research. Clinically, Yvonne treats predominantly breast, skin, upper gastro-intestinal and haematological cancers.

With a strong interest in clinical research and working as an advocate for cancer patients, Yvonne believes in making exercise a part of treatment for all cancer patients, and exploring new ways of improving the patient’s cancer journey.

More from this expert

A/Prof Yvonne Zissiadis discusses the pivotal role radiation therapy plays in the management and treatment of breast cancer.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.